Found 87 matching trials
A Study of GC203 TIL in Advanced Gynecologic Tumors (10hospital)
EARLY_PHASE1This study is to investigate the safety and efficacy on TIL engineered with...
Location
Shanghai Tenth People's Hospital
HS-IT201 Injection in the Treatment of Advanced Solid Tumors
EARLY_PHASE1Single-arm, open-label,interventional study evaluating adoptive cell therap...
Location
Multiple Locations
A Clinical Study on TILs for the Treatment of Advanced Solid Tumors
EARLY_PHASE1This study is an open exploratory clinical study to evaluate the safety, to...
Location
Multiple Locations
Lymphocyte Re-infusion During Immune Suppression to Treat Metastatic Melanoma
PHASE2This experiment will test the safety and effectiveness of a treatment for m...
Location
National Cancer Institute (NCI)
A Study of GC101 TIL in Advanced Solid Tumors (TR)
EARLY_PHASE1This study is to investigate the safety and efficacy of tumor infiltrating ...
Location
Tongren Hospital Shanghai Jiao Tong University School Of Medicine.
Hema-NeoTIL01 Cell Infusion Therapy in Relapsed/Refractory Acute Leukemia
EARLY_PHASE1This clinical trial aims to investigate the safety, optimal dosage, and eff...
Location
The First Affiliated Hospital of Soochow University
Autologous Tumor-Infiltrating Lymphocyte (GT307 Injection ) for Treatment of Patients With Solid Tumours
NAThis study is a single arm, open design aimed at evaluating the safety and ...
Location
Beijing Arion Cancer Center
Gene-Modified T Cells With or Without Decitabine in Treating Patients With Advanced Malignancies Expressing NY-ESO-1
PHASE1This phase I/IIa trial studies the side effects and best dose of gene-modif...
Status
Active Not Recruiting
Location
Roswell Park Cancer Institute
Study of GC101 TIL in Brain Glioma (Soochow2)
EARLY_PHASE1This study is to investigate the safety and efficacy of tumor infiltrating ...
Location
The Second Affiliated Hospital of Soochow University
HS-IT101 Injection in the Treatment of Advanced Melanoma
PHASE1Single-arm, open-label,interventional study evaluating adoptive cell therap...
Status
Enrolling By Invitation
Location
Peking University Cancer Hospital